The Myth of Vendor Fit: How to Read RFPs Beyond the Polish
A practical conversation on how biotechs can read RFPs differently, avoid the fluency trap, challenge assumptions, and choose vendors that can actually deliver.
Every biotech faces this moment: the RFP looks perfect, polished, aligned, convincing. But does it actually signal readiness?
In this episode, Seuss+ CEO Kieran Engels joins Julia Vassiliadou (F2G) to break down why a beautiful proposal can mislead sponsors, what real signals of vendor readiness look like, and how biotechs can tailor the selection process to avoid costly mistakes.
Together, they unpack: Why we confuse polish with capability The four signals that a vendor is genuinely ready How to challenge assumptions during bid defenses Why risk-based thinking (ICH E6 R3) should shape sponsor decision-making How governance, oversight, and setup determine long-term CRO success Whether you’re selecting your first CRO or refining your next vendor strategy, this conversation gives you the tools to see beyond the surface and choose smarter.
🎧 Listen now and don’t let polish fool you.
Liked this episode? Get our monthly LinkedIn newsletter directly to your inbox.
Sign up to stay up-to-date with the business of science, industry news, developing trends, and key insights.